Related Experiment Video
Updated: Mar 14, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Statin intolerance - a question of definition
Engi Abdel-Hady Algharably1,2, Iris Filler1, Stephanie Rosenfeld3
1a Institut für Klinische Pharmakologie und Toxikologie , Charité - Universitätsmedizin Berlin , Berlin , Germany.
Introduction:
Statin therapy is the backbone of pharmacologic therapy for low-density lipoproteins cholesterol lowering and plays a pivotal role in cardiovascular disease prevention. Statin intolerance is understood as the inability to continue using a statin to reduce individual cardiovascular risk sufficiently, due to the development of symptoms or laboratory abnormalities attributable to the initiation or dose escalation of a statin. Muscle symptoms are the most common side effects observed. Areas covered: The main aim of this article is to present a review on published definitions of statin intolerance. In addition, a brief review on clinical aspects and risk factors of statin intolerance is provided and features for a common definition for statin intolerance are suggested. Expert opinion: A definition of statin intolerance by major drug regulatory agencies is not available. In clinical studies, different definitions are chosen and results are not comparable; different medical associations do not agree on one common definition. There is an unmet need to establish a common definition of statin intolerance to ensure an appropriate clinical use of this important drug class. Further work is required to develop a consensus definition on statin intolerance that could have significant positive impact on both research and clinical management.
Insights
Statin intolerance, often causing muscle symptoms, prevents effective cardiovascular risk reduction. A common definition is needed for consistent clinical use and research of statin therapy.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Statin therapy is crucial for lowering low-density lipoproteins cholesterol and preventing cardiovascular disease.
- Statin intolerance is defined as the inability to continue statin therapy due to side effects, most commonly muscle symptoms.
- Current definitions of statin intolerance vary, hindering comparable clinical study results.
Purpose of the Study:
- To review published definitions of statin intolerance.
- To provide a brief overview of clinical aspects and risk factors associated with statin intolerance.
- To suggest features for a common definition of statin intolerance.
Main Methods:
- Literature review of published definitions of statin intolerance.
- Analysis of clinical aspects and risk factors.
- Synthesis of features for a consensus definition.
Main Results:
- No universally accepted definition of statin intolerance exists from major drug regulatory agencies.
- Disparate definitions used in clinical studies lead to non-comparable outcomes.
- Lack of consensus among medical associations complicates clinical management.
Conclusions:
- There is a significant unmet need for a common definition of statin intolerance.
- Establishing a consensus definition is essential for appropriate clinical use and effective research.
- Further work is required to develop a widely accepted definition for improved patient outcomes and research standardization.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacokinetics: Drug–Drug Interactions
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Dipeptidyl Peptidase 4 Inhibitors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

